- Home
- CNTB vs VATE Comparison
CNTB vs VATE Comparison
Compare CNTB & VATE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CNTB
- VATE
- Stock Information
- Founded
- CNTB 2012
- VATE 1994
- Country
- CNTB United States
- VATE United States
- Employees
- CNTB N/A
- VATE N/A
- Industry
- CNTB Biotechnology: Pharmaceutical Preparations
- VATE Metal Fabrications
- Sector
- CNTB Health Care
- VATE Industrials
- Exchange
- CNTB Nasdaq
- VATE Nasdaq
- Market Cap
- CNTB 54.4M
- VATE 70.3M
- IPO Year
- CNTB 2021
- VATE 1996
- Fundamental
- Price
- CNTB $1.46
- VATE $5.34
- Analyst Decision
- CNTB Strong Buy
- VATE
- Analyst Count
- CNTB 2
- VATE 0
- Target Price
- CNTB $7.50
- VATE N/A
- AVG Volume (30 Days)
- CNTB 148.9K
- VATE 17.6K
- Earning Date
- CNTB 09-04-2025
- VATE 08-06-2025
- Dividend Yield
- CNTB N/A
- VATE N/A
- EPS Growth
- CNTB N/A
- VATE N/A
- EPS
- CNTB N/A
- VATE N/A
- Revenue
- CNTB $26,033,000.00
- VATE $1,066,100,000.00
- Revenue This Year
- CNTB N/A
- VATE N/A
- Revenue Next Year
- CNTB N/A
- VATE N/A
- P/E Ratio
- CNTB N/A
- VATE N/A
- Revenue Growth
- CNTB N/A
- VATE N/A
- 52 Week Low
- CNTB $0.51
- VATE $3.25
- 52 Week High
- CNTB $1.60
- VATE $13.79
- Technical
- Relative Strength Index (RSI)
- CNTB 72.56
- VATE 45.53
- Support Level
- CNTB $1.05
- VATE $5.23
- Resistance Level
- CNTB $1.56
- VATE $5.76
- Average True Range (ATR)
- CNTB 0.13
- VATE 0.24
- MACD
- CNTB 0.04
- VATE 0.04
- Stochastic Oscillator
- CNTB 84.59
- VATE 41.67
About CNTB Connect Biopharma Holdings Limited
Connect Biopharma Holdings Ltd is a clinical-stage company focused on the discovery and development of next-generation immune modulators for the treatment of serious autoimmune diseases and inflammation. It has leveraged its expertise in the biology of T cell modulation to build a portfolio of drug candidates consisting of small molecules and antibodies targeting critical pathways of inflammation. Its pipeline includes CBP-201, CBP-307 and CBP-174.
About VATE INNOVATE Corp.
Innovate Corp is a diversified holding company that has a portfolio of subsidiaries in a variety of operating segments which are; The infrastructure segment is comprised of DBM Global Inc, a fully integrated industrial construction, structural steel, and facility maintenance provider that provides fabrication and erection of structural steel and heavy steel plate services, The Life Sciences segment is comprised of Pansend Life Sciences which seeks to develop products to treat early osteoarthritis of the knee and aesthetic and medical technologies for the skin, and Spectrum segment is comprised of HC2 Broadcasting Holdings Inc which operates over-the-air broadcasting station across the United States.